These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1856259)

  • 1. The incidence of thyroid stimulating blocking antibodies during the hypothyroid phase in patients with subacute thyroiditis.
    Tamai H; Nozaki T; Mukuta T; Morita T; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1991 Aug; 73(2):245-50. PubMed ID: 1856259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.
    Chiovato L; Vitti P; Santini F; Lopez G; Mammoli C; Bassi P; Giusti L; Tonacchera M; Fenzi G; Pinchera A
    J Clin Endocrinol Metab; 1990 Jul; 71(1):40-5. PubMed ID: 2164529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis.
    Iitaka M; Momotani N; Hisaoka T; Noh JY; Ishikawa N; Ishii J; Katayama S; Ito K
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):445-53. PubMed ID: 9640411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis.
    Takasu N; Yamada T; Takasu M; Komiya I; Nagasawa Y; Asawa T; Shinoda T; Aizawa T; Koizumi Y
    N Engl J Med; 1992 Feb; 326(8):513-8. PubMed ID: 1732791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Lancet; 1990 Nov; 336(8723):1084-6. PubMed ID: 1977978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan.
    Tamaki H; Amino N; Kimura M; Hidaka Y; Takeoka K; Miyai K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of autoimmune hypothyroidism and subsequent hyperthyroidism by TSH receptor antibodies following subacute thyroiditis: a case report.
    Iitaka M; Kakinuma S; Yamanaka K; Fujimaki S; Oosuga I; Wada S; Katayama S
    Endocr J; 2001 Apr; 48(2):139-42. PubMed ID: 11456259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSH receptor antibodies in autoimmune thyroiditis.
    Nordmeyer JP; Hashim FA; Shafeh T; Eickenbusch W; Rees Smith B
    J Clin Lab Immunol; 1988 May; 26(1):21-4. PubMed ID: 3184158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of hypothyroidism with simultaneous presence of stimulating type anti-thyrotropin (TSH) receptor antibodies and anti-thyroxine (T4) autoantibodies.
    Ohshiro K; Sakata S; Matsuda M; Komaki T; Saito M; Goshima E; Kitada M
    Endocrinol Jpn; 1992 Jun; 39(3):245-50. PubMed ID: 1425450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute thyroiditis with thyroid-stimulation blocking antibodies: a case report.
    Nakamura S; Saio Y; Suzuki E
    Endocr J; 1996 Apr; 43(2):185-9. PubMed ID: 8793334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of antibodies to thyrotropin receptors and to thyroid ultrasonographic volume in euthyroid and hypothyroid patients with autoimmune thyroiditis.
    Rieu M; Portos C; Lissak B; Laplanche S; Sambor B; Berrod JL; Fombeur JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):641-5. PubMed ID: 8636282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of thyroid antibodies].
    Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG
    Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The functional outcome of patients with subacute thyroiditis].
    Ishizuki Y; Hirooka Y; Murata Y; Togashi K
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):154-65. PubMed ID: 1582521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis.
    Morita T; Tamai H; Oshima A; Mukuta T; Fukata S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1051-5. PubMed ID: 1976125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH; Eng PH; Ho SC; Fok AC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.